Skip to main content
  • 196 Accesses

Abstract

Generally, in out-patient practice an antibiotic is chosen after making a clinical diagnosis and taking into account the most probable causative agents of that particular type of infection. Except in urinary tract infections and some cases of middle ear and throat infections, etiological microbiological tests are rarely done. The dose and duration of antibiotic therapy is decided on empirical bases. Even at hospitals, where more than one-third of the admitted patients obtain antibiotics during the visit (Pestotnik et al. 1990), microbiological diagnosis of the suspected bacterial infection is available in less than half of the cases (Moss et al. 1983). Again, in most instances the treatment is empirical. The dose of antibiotic is determined by crude patient data, such as weight or surface area, age and renal function if the drug is eliminated by kidneys. Excellent handbooks are available for a more individualized prescription of antibiotics (e.g. Norris et al. 1989). These also give the drug concentrations obtained in serum and some other body fluids for the most commonly used doses and ways of administration. Microcomputer-based programs to assist clinical pharmacokinetic consultant services have been developed for aminoglycosides and some other antibiotics (Schentag and Adelman 1983). These may decrease the need for serum concentration measurements of antibiotics (Lumio 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson AC, Hodges GR, Barnes WG (1976) Determination of serum gentamicin sulfate levels: ordering patterns and use as a guide to therapy. Arch Intern Med 136: 785–787

    Article  PubMed  CAS  Google Scholar 

  • Anderson ET, Young LS, Hewitt WL (1976) Simultaneous antibiotic levels in “breakthrough” gram-negative rod bacteremia. Am J Med 61: 493–497

    Article  PubMed  CAS  Google Scholar 

  • Arcieri GM, Becker N, Esposito B, Griffith E, Heyd A, Neumann C, O’Brien B, Schacht P (1989) Safety of intravenous ciprofloxacin. Am J Med 87 (Suppl 5A): 925–978

    Article  Google Scholar 

  • Bergan T, Engeset A, Olszewski W (1987) Does serum protein binding inhibit tissue penetration of antibiotics? Rev Infect Dis 9: 713–718

    Article  PubMed  CAS  Google Scholar 

  • Black J, Hunt TL, Godley PJ, Matthew E (1987) Oral antimicrobial therapy for adults with osteomyelitis or septic arthritis. J Infect Dis 155: 968–972

    Article  PubMed  CAS  Google Scholar 

  • Calain P, Waldvogel F (1990) Clinical efficacy of teicoplanin. Eur J Clin Microbiol Infect Dis 9: 127–129

    Article  PubMed  CAS  Google Scholar 

  • Carbon C, Weber P, Levy M, Boussougant Y, Cerf M (1987) Short-term ciprofloxacin therapy for typhoid fever. J Infect Dis 155: 883–889

    Article  Google Scholar 

  • Cipolle RJ, Seifert RD, Zaske DE, Strate RG (1980) Systemically individualizing tobramycin dosage regimens. J Clin Pharmacol 20: 570–580

    PubMed  CAS  Google Scholar 

  • Don Brown R, Campoli-Richards DM (1989) Antimicrobial therapy in neonates, infants and children. Clin Pharmacokinet 17 (Suppl 1): 105–115

    Article  PubMed  Google Scholar 

  • Groot R de, Smith AL (1987) Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance. Clin Pharmacokinet 13: 228–253

    Article  PubMed  Google Scholar 

  • Lietman PS (1989) Pharmacokinetics of antimicrobial agents. In: Mandell GL, Douglas Jr RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 228–230

    Google Scholar 

  • Lumio J (1987) Tehokas ja turvallinen aminoglykosidihoito — onko ATK:sta apua. Suom Lääkäril 42: 271–277

    Google Scholar 

  • Manian FA, Stone WJ, Alford RH (1990) Adverse antibiotic effects associated with renal insufficiency 12: 236–249

    CAS  Google Scholar 

  • Meyers BR, Wilkinson P (1989) Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection of dosage. Clin Pharmacokinet 17: 385–395

    Article  PubMed  CAS  Google Scholar 

  • Moore RD, Lietman PS, Smith CR (1987) Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 155: 93–99

    Article  PubMed  CAS  Google Scholar 

  • Moss F, McNicol MW, McSwiggan DA, Miller DL (1983) Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. Lancet II: 349–352

    Google Scholar 

  • Nix DE, Sands MF, Peloquin CA, Vari AJ, Cumbo TJ, Vance JW, Fracasso JE, Schentag JJ (1987) Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections. Am J Med 82 (Suppl 4A): 352–256

    PubMed  CAS  Google Scholar 

  • Noone P, Parsons TMC, Pattison JR, Slack RCB, Garfield-Davis D (1974) Experience in monitoring gentamycin therapy during treatment of serious gram-negative sepsis. Br Med J I: 477–481

    Article  Google Scholar 

  • Norris S, Nightingale CH, Mandell GL (1989) Tables of antimicrobial agent pharmacology. In: Mandell GL, Douglas Jr RG, Bennett JE (eds) Principles and practice of infectious diseases, 3rd edn. Churchill Livingstone, New York, pp 434–460

    Google Scholar 

  • Peltola H, Anttila M, Renkonen O-V and the Finnish Study Group (1989) Randomized comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Lancet L 1281–1287

    Google Scholar 

  • Pestotnik SL, Evans RS, Burke JP, Gardner RM, Classen DC (1990) Therapeutic antibiotic monitoring: surveillance using a computerized expert system. Am J Med 88: 43–48

    Article  PubMed  CAS  Google Scholar 

  • Ryan DM, Cars O, Hoffstedt B (1986) The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 18: 381–388

    Article  PubMed  CAS  Google Scholar 

  • Ryback SA, Lerner DP, Levine LM, Albrecht PL, McNeil GA, Thompson MT, Kenny W (1989) Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Interscience Conf Antimicrobial agents and chemotherapy, Abstr 1343

    Google Scholar 

  • Schentag JJ (1989) Clinical significance of antibiotic tissue penetration. Clin Pharmacokinet 16: 25–31

    Article  PubMed  CAS  Google Scholar 

  • Schentag JJ, Adelman MH (1983) A microcomputer program for tobramycin consult services, based on the two-compartment pharmacokinetic model. Drug Intell Clin Pharm 17: 528–531

    PubMed  CAS  Google Scholar 

  • Schentag JJ, Smith IL, Swanson DJ, de Angelis C, Fracasso JE, Vari A, Vance JW (1984) Role for dual individualization with cefmenoxime. Am J Med 77 (Suppl 6A): 43–50

    PubMed  CAS  Google Scholar 

  • Soe GB, Overturf GD (1987) Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, cefoperazone and other new cephalosporins. Rev Infect Dis 9: 719–736

    Article  PubMed  CAS  Google Scholar 

  • Tack KJ, Sabath LD (1982) The significance of serum levels of antimicrobial agents. In: Lourian V (ed) Significance of medical microbiology in the case of patients, USA pp 383–393

    Google Scholar 

  • Wenk W, Vozeh S, Follath F (1984) Serum level monitoring of antibacterial drugs. A review. Clin Pharmacokinet 9: 475–492

    Article  PubMed  CAS  Google Scholar 

  • Wolfson JS, Swartz MN (1985) Serum bactericidal activity as a monitor of antibiotic therapy. N Engl J Med 312: 968–975

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lumio, J. (1991). Clinical Needs for Assays of New Antimicrobial Agents. In: Vaheri, A., Tilton, R.C., Balows, A. (eds) Rapid Methods and Automation in Microbiology and Immunology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76603-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76603-9_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76605-3

  • Online ISBN: 978-3-642-76603-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics